Imricor Medical Systems, Inc. announced the first three cardiac ablation procedures were completed in the first clinical study that is evaluating the feasibility of their magnetic resonance (MR)-enabled products to treat atrial flutter. Prof. Reza Razavi, head of the Division of Imaging Sciences and Biomedical Engineering, King's College London, is the principal investigator for the study and performed the procedures along with Mark O'Neill, professor of cardiac electrophysiology and consultant cardiologist, Guy's and St. Thomas' NHS Trust in the United Kingdom, The prospective pilot study will enroll up to 15 patients at this center.

AtriCure Synergy Ablation System

Medical imaging is at the forefront of diagnostics today, with imaging techniques like magnetic resonance imaging (MRI), computerized tomography (CT), scanning and nuclear magnetic resonance (NMR) increasing steeply over the last two decades. However, persisting problems of image resolution and quality still limit these techniques because of the nature of living tissue. A solution is hyperpolarization, which involves injecting the patient with substances that can increase imaging quality by following the distribution and fate of specific molecules in the body but that can be harmful or potentially toxic to the patient. A team of scientists from EPFL, CNRS, ENS and CPE Lyon and ETH Zürich has developed a new generation of hyperpolarization agents that can be used to dramatically enhance the signal intensity of imaged body tissues without presenting any danger to the patient. Their work is published in Proceedings of the National Academy of Sciences (PNAS).

October 15, 2014 — Imaging can be a cost-effective way to identify people at risk for stroke who might benefit from aggressive intervention, according to a new modeling study published online in the journal Radiology.

Veterinary CyberKnife Cancer Center (VC3), a privately owned advanced radiation treatment center for veterinary use, today announced the opening of its facility in Malvern, Pa. The CyberKnife is a non-invasive way to deliver radiation to tumors, enabling treatment with greater precision than traditional linear accelerators and intensity modulated radiation therapy (IMRT) machines. The CyberKnife delivers an entire therapeutic dose of radiation in one to three treatments versus 17 to 20 treatments of traditional radiation therapy. VC3 has changed the way companion animals with cancerous tumors are treated.

Ion Beam Applications SA (IBA) announced that the University of Iowa and IBA have signed a research collaboration agreement and a technology license agreement to develop ultra-high precision intensity modulated proton therapy (IMPT). This agreement includes an exclusive license on the Dynamic Collimation System (DCS) recently developed and presented by the University of Iowa at the American Association of Physicists in Medicine (AAPM) meeting in Austin, Texas.

The Radiological Society of North America (RSNA) has received an additional $1.27 million of funding from the National Institute of Biomedical Imaging and Bioengineering (NIBIB) to support research by the Quantitative Imaging Biomarkers Alliance (QIBA). This marks the fourth consecutive year that NIBIB has funded research groundwork by QIBA, following a 2013 contract for $1.25 million.

Individuals and organizations providing or increasing access to quality radiological services for patients in low-to middle-income countries and underserved areas of the United States are encouraged to apply for the American College of Radiology Foundation’s (ACRF) new Global Humanitarian Awards. Award applicants may either be self-nominated or nominated by a peer.

The Geneva Healthcare Suite has been proven effective by clinicians at the Douglas & Nancy Barnhart Cancer Center at Sharp Chula Vista Medical Center in managing risk for patients with cardiac devices undergoing radiation therapy.

A new survey entitled "Diagnosis Anxiety: The Working Mother Breast Screening Report" sheds important new information on the level of awareness women have about breast cancer today and what they are doing to help reduce the disease or detect it early.

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now